Novo Nordisk A S NVO
NYSE NVO
$38.63 +0.48 (+1.26%)
At close: Oct 9, 2026 · 4:00 PM EDT

Novo Nordisk A S (NVO) Common Equity (2013 - 2016)

Updated

Novo Nordisk A S (NVO) posted Common Equity of $45.27 billion for Q4 2016, down 3.6% from $46.97 billion a year earlier.

Analysis

Novo Nordisk A S (NVO) Common Equity (2013 - 2016) Analysis & Trends

Since Q4 2013, Novo Nordisk A S has reported Common Equity for 4 quarters.

  • Annual Common Equity shows a three-year compound annual growth rate of 2.1% (FY2013 to FY2016).
  • In prior years, Novo Nordisk A S's Common Equity was $46.97 billion in FY2015 (+16.6%), $40.29 billion in FY2014 (-5.3%) and $42.57 billion in FY2013.
  • The Q4 2016 figure stands as the lowest quarterly Common Equity since Q4 2014.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 45.27 Bn
Dec 31, 2015 46.97 Bn
Dec 31, 2014 40.29 Bn
Dec 31, 2013 42.57 Bn
API Access

Novo Nordisk A S Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=NVO&period=max&api_key=YOUR_API_KEY